ARALEZ PHARMACEUTICALS INC. Business Combination, Contingent Consideration, Liability, Current
ARALEZ PHARMACEUTICALS INC. had Business Combination, Contingent Consideration, Liability, Current of $10.46 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2018-05-08
- 2018-03-31: Business Combination, Contingent Consideration, Liability, Current $10.46M.
- 2017-12-31: Business Combination, Contingent Consideration, Liability, Current $11.48M.
- 2017-09-30: Business Combination, Contingent Consideration, Liability, Current $8.93M.
- 2017-06-30: Business Combination, Contingent Consideration, Liability, Current $9.15M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2018-03-31 | $10.46M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $11.48M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $8.93M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $9.15M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $10.27M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $10.43M 10-K · filed 2018-03-14 |
| 2016-09-30 | $600.00K 10-Q · filed 2016-11-08 |